Improving diagnosis of Parkinson's disease using advanced MRI techniques
Official title: Statistical Methods for Biomarkers Identification Using High-resolution Diffusion MRI
Funded at University of Illinois at Chicago · NIH-10828863 · Data updated 2026-11-12
This study is looking to improve how we diagnose Parkinson's disease by using advanced MRI scans to find new clues about the disease's progression, which could help doctors make more accurate diagnoses for patients.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | May 1, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $79,950 |
| NIH project number | 5R03NS128450-02 |
| Project ID | NIH-10828863 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing symptoms of Parkinson's disease or those at risk of developing the condition.
✕Less likely to help
Patients who do not have Parkinson's disease or related neurodegenerative disorders may not benefit from this research.
What this research studies
This research focuses on enhancing the accuracy of Parkinson's disease diagnosis through the use of high-resolution diffusion MRI. By developing new statistical methods, the study aims to identify imaging biomarkers that can provide clearer insights into the disease's progression. The approach involves analyzing detailed MRI data to uncover patterns that traditional methods may miss, ultimately leading to better diagnostic tools. Patients' clinical information will also be integrated to improve the overall understanding of the disease.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier diagnoses of Parkinson's disease, improving patient outcomes.
How similar studies have gone: Previous studies using advanced imaging techniques have shown promise in improving diagnostic accuracy for neurodegenerative diseases, indicating potential success for this approach.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Zhong, Ping-Shou — University of Illinois at Chicago
- Study coordinator: Zhong, Ping-Shou
Related research
Other NIH-funded projects on the same topics.
-
MSC Secretome Eye Drops to Speed Healing of Corneal Wounds
A new eye drop made from stem cell–secreted factors is being tested to help adults with non-healing corneal wounds recover vision faster.
-
UIC Center for Healthy Work
A national program led by UIC aims to improve the health and well-being of workers through collaborative research and practical solutions.
-
Coordinated Oral Health Promotion for Chicago Kids
A long-running study in Chicago is following children and their caregivers to find ways to reduce tooth decay and improve daily life for families.
-
Targeting p38 MAPK to slow ALS-related axonal damage
Aims to block a specific brain-wide signaling pathway (p38 MAPK) to reduce nerve damage in people with various genetic forms of ALS.
-
Precision nanomedicine to calm inflammation and protect bone in gum disease
A new, targeted nanomedicine approach aims to reduce gum inflammation and prevent bone loss in adults with periodontal disease.
-
Role of DPP in Dental Pulp Stem Cells and their Regenerative Potential
A project explores how a natural tooth protein helps dental pulp stem cells repair and regenerate the tooth’s inner tissue.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.